SARS-CoV-2 vs. Hepatitis Virus Infection Risk in the Hemodialysis Population: What Should We Expect?
| العنوان: | SARS-CoV-2 vs. Hepatitis Virus Infection Risk in the Hemodialysis Population: What Should We Expect? |
|---|---|
| المؤلفون: | Elena Gimenez-Civera, María Jesús Puchades, Pablo Molina, Lorena Gandía, Sergio Romero-Alcaide, Miguel A. Serra, Javier Reque, Nayara Panizo, José Luis Górriz, Luis D'Marco |
| المصدر: | International Journal of Environmental Research and Public Health International Journal of Environmental Research and Public Health, Vol 18, Iss 5748, p 5748 (2021) |
| بيانات النشر: | MDPI, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | medicine.medical_specialty, COVID19, Health, Toxicology and Mutagenesis, medicine.medical_treatment, Population, 030232 urology & nephrology, medicine.disease_cause, 03 medical and health sciences, 0302 clinical medicine, Renal Dialysis, Seroepidemiologic Studies, Pandemic, Hepatitis Viruses, medicine, Seroprevalence, Humans, hepatitis, Intensive care medicine, education, Coronavirus, Hepatitis, education.field_of_study, business.industry, Transmission (medicine), SARS-CoV-2, Public Health, Environmental and Occupational Health, virus diseases, COVID-19, medicine.disease, Vaccination, Editorial, Medicine, dialysis, 030211 gastroenterology & hepatology, Hemodialysis, business, chronic kidney disease |
| الوصف: | Since the dramatic rise of the coronavirus infection disease 2019 (COVID-19) pandemic, patients receiving dialysis have emerged as especially susceptible to this infection because of their impaired immunologic state, chronic inflammation and the high incidence of comorbidities. Although several strategies have thus been implemented to minimize the risk of transmission and acquisition in this population worldwide, the reported severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence varies across studies but is higher than in the general population. On the contrary, the screening for hepatitis viruses (HBV and HCV) has seen significant improvements in recent years, with vaccination in the case of HBV and effective viral infection treatment for HCV. In this sense, a universal SARS-CoV-2 screening and contact precaution appear to be effective in preventing further transmission. Finally, regarding the progress, an international consensus with updated protocols that prioritize between old and new indicators would seem a reasonable tool to address these unexpended changes for the nephrology community. |
| اللغة: | English |
| تدمد: | 1660-4601 1661-7827 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e411c46029e00ca1cc238a00b0342161 http://europepmc.org/articles/PMC8198690 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....e411c46029e00ca1cc238a00b0342161 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 16604601 16617827 |
|---|